JULIA KNAPP: Open Payments
NPI 1598704751 · MACON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 20 payments from 8 companies in 2025. Trend: 2023 $354 · 2024 $154 · 2025 $499
Food & beverage: $483Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $206 |
| ABBVIE INC. | 3 | $65 |
| PFIZER INC. | 3 | $53 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Verona Pharma, Inc. | 1 | $20 |
Products named: BREZTRI, VRAYLAR, JOURNAVX, CAPLYTA, Qelbree, REXULTI, NURTEC ODT, PREVNAR 20.
Industry payments across MO — which companies pay providers there.
